Memorial Sloan Kettering Cancer Center

Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1 (2023) Hensley PJ, Seiler R, Herr H, Mouw KW, Iyer G, Dyrskjøt L, Nawroth R, et al. Journal article, Review article Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database (2023) Bickel H, Clauser P, Pinker K, Helbich T, Biondic I, Brkljacic B, Dietzel M, et al. Journal article Quality of life with ribociclib versus abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison (2023) Rugo HSS, Harmer V, O'Shaughnessy J, Jhaveri K, Tolaney SMM, Cardoso F, Bardia A, et al. Journal article Datasets for reporting of soft-tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) (2023) Tos APD, Webster F, Agaimy A, Bovée J, Dickson B, Doyle L, Dry S, et al. Journal article Reply to Yongbao Wei, Haijian Huang, and Liefu Ye's Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469–82. (2023) Rubin MA, Amin MB, Compérat E, Gill A, Hartmann A, Menon S, Raspollini M, et al. Journal article The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms (2023) Machado I, Agaimy A, Giner F, Navarro S, Michal M, Bridge J, Claramunt R, et al. Journal article A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2 (2023) Zanti M, O'Mahony DG, Parsons MT, Li H, Dennis J, Aittomäkkiki K, Andrulis IL, et al. Journal article Identification of impactful imaging biomarker: Clinical applications for breast and prostate carcinoma (2023) Bäuerle T, Dietzel M, Pinker K, Bonekamp D, Zhang KS, Schlemmer HP, Bannas P, et al. Journal article, Review article Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer (2023) Jhaveri K, O’Shaughnessy J, Fasching PA Journal article Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners (2022) Dermawan JKK, Dashti N, Chiang S, Turashvili G, Dickson BCC, Ellenson LHH, Kirchner M, et al. Journal article